NexgenRx Reports Strong Q2 Growth and SaaS Success
Company Announcements

NexgenRx Reports Strong Q2 Growth and SaaS Success

Story Highlights

NexgenRx (TSE:NXG) has released an update.

NexgenRx, a Canadian Third-Party Administrator and Technology Solutions Provider, has reported a substantial 19% revenue increase and a positive EBITDA in its second quarter of 2024. The growth is attributed to the successful introduction of SaaS solutions and a strong sales pipeline. The company remains in a strong cash position, even after paying out dividends to shareholders.

For further insights into TSE:NXG stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskNexgenRx Welcomes Charles Burns Back to Board
TipRanks Canadian Auto-Generated NewsdeskNexgenRx Welcomes New Expertise to Board
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App